These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10555144)

  • 1. A molecular target for viral killer toxin: TOK1 potassium channels.
    Ahmed A; Sesti F; Ilan N; Shih TM; Sturley SL; Goldstein SA
    Cell; 1999 Oct; 99(3):283-91. PubMed ID: 10555144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to K1 killer toxin: internal TOK1 blockade.
    Sesti F; Shih TM; Nikolaeva N; Goldstein SA
    Cell; 2001 Jun; 105(5):637-44. PubMed ID: 11389833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kre1p, the plasma membrane receptor for the yeast K1 viral toxin.
    Breinig F; Tipper DJ; Schmitt MJ
    Cell; 2002 Feb; 108(3):395-405. PubMed ID: 11853673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viruses activate a genetically conserved cell death pathway in a unicellular organism.
    Ivanovska I; Hardwick JM
    J Cell Biol; 2005 Aug; 170(3):391-9. PubMed ID: 16061692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast K1 killer toxin forms ion channels in sensitive yeast spheroplasts and in artificial liposomes.
    Martinac B; Zhu H; Kubalski A; Zhou XL; Culbertson M; Bussey H; Kung C
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6228-32. PubMed ID: 1696721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer-toxin-resistant kre12 mutants of Saccharomyces cerevisiae: genetic and biochemical evidence for a secondary K1 membrane receptor.
    Schmitt MJ; Compain P
    Arch Microbiol; 1995 Dec; 164(6):435-43. PubMed ID: 8588746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different action of killer toxins K1 and K2 on the plasma membrane and the cell wall of Saccharomyces cerevisiae.
    Novotná D; Flegelová H; Janderová B
    FEMS Yeast Res; 2004 Sep; 4(8):803-13. PubMed ID: 15450187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast viral killer toxins: lethality and self-protection.
    Schmitt MJ; Breinig F
    Nat Rev Microbiol; 2006 Mar; 4(3):212-21. PubMed ID: 16489348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K1 killer toxin, a pore-forming protein from yeast.
    Bussey H
    Mol Microbiol; 1991 Oct; 5(10):2339-43. PubMed ID: 1724277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing of Candida albicans by human salivary histatin 5 is modulated, but not determined, by the potassium channel TOK1.
    Baev D; Rivetta A; Li XS; Vylkova S; Bashi E; Slayman CL; Edgerton M
    Infect Immun; 2003 Jun; 71(6):3251-60. PubMed ID: 12761106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral induced yeast apoptosis.
    Schmitt MJ; Reiter J
    Biochim Biophys Acta; 2008 Jul; 1783(7):1413-7. PubMed ID: 18291112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and molecular approaches to synthesis and action of the yeast killer toxin.
    Bussey H; Boone C; Zhu H; Vernet T; Whiteway M; Thomas DY
    Experientia; 1990 Feb; 46(2):193-200. PubMed ID: 2406163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the gamma component of preprotoxin in expression of the yeast K1 killer phenotype.
    Zhu YS; Kane J; Zhang XY; Zhang M; Tipper DJ
    Yeast; 1993 Mar; 9(3):251-66. PubMed ID: 8488726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of plasma membrane potential changes in Saccharomyces cerevisiae cells reveal the importance of the Tok1 channel in membrane potential maintenance.
    Maresova L; Urbankova E; Gaskova D; Sychrova H
    FEMS Yeast Res; 2006 Nov; 6(7):1039-46. PubMed ID: 17042753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium uptake through the TOK1 K+ channel in the budding yeast.
    Fairman C; Zhou X; Kung C
    J Membr Biol; 1999 Mar; 168(2):149-57. PubMed ID: 10089235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of Saccharomyces cerevisiae mutants with a different degree of resistance to killer toxins K1 and K2.
    Flegelová H; Novotná D; Vojtísková K; Janderová B
    FEMS Yeast Res; 2002 Mar; 2(1):73-9. PubMed ID: 12702323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Yeast Killer Toxin K1 Precursor Processing via Site-Directed Mutagenesis: Implications for Toxicity and Immunity.
    Gier S; Schmitt MJ; Breinig F
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32051241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the functional domains of yeast K1 killer toxin.
    Zhu H; Bussey H
    Mol Cell Biol; 1991 Jan; 11(1):175-81. PubMed ID: 1702512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOK1 is a volatile anesthetic stimulated K+ channel.
    Gray AT; Winegar BD; Leonoudakis DJ; Forsayeth JR; Yost CS
    Anesthesiology; 1998 Apr; 88(4):1076-84. PubMed ID: 9579518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel yeast gene, RHK1, is involved in the synthesis of the cell wall receptor for the HM-1 killer toxin that inhibits beta-1,3-glucan synthesis.
    Kimura T; Kitamoto N; Kito Y; Iimura Y; Shirai T; Komiyama T; Furuichi Y; Sakka K; Ohmiya K
    Mol Gen Genet; 1997 Mar; 254(2):139-47. PubMed ID: 9108275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.